Markets
Superstars
Analyst Estimates
Alerts
Screeners
Subscribe
Calendar
ETFs
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
Explore
FAQs
Widgets
More
Search stocks
IND
USA
USA
USA
×
Close
IND
USA
Stocks
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Citius Oncology Inc.
Swot
Citius Oncology Inc. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Citius Oncology Inc. has 11 Strengths, 8 Weaknesses, 5 Opportunities and 0 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(11)
Weakness
(8)
Opportunity
(5)
Threats
(0)
Others
(0)
Price crossing above SMA20 today, and greater than SMA5
Relative Outperformance versus Industry over 1 Week
Significant (over 30%) distance from 52 week high
Rising Net Cash Flow and Cash from Operating activity
Stocks whose current price is 20% higher than week low, and more than previous close
Relative Outperformance versus Industry over 1 Week
Company with Low Debt
High Volume, High Gain
Top Gainers
Volume Shockers
High Volume, High Gain
Stocks with Quarter Change % less than Industry
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Lowest Momentum Scores (Technical Scores)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Highest fall from 52 Week High
Low Piotroski Score : Companies with weak financials
Weak performer : Stock lost more than 20% in 1 month
Stocks Underperforming their Industry Price Change in the Quarter
Mutual Funds Increased Shareholding in Past Month
Institutions increasing their shareholding
Mutual Funds Increased Shareholding over the Past Two Months
MFs increased their shareholding last quarter
Mf buying for 2 months
